Benzinga | Aug 12, 2021 05:02PM EDT

Evoke Pharma Q2 EPS $(0.07) Beats $(0.08) Estimate

Evoke Pharma (NASDAQ:EVOK) reported quarterly losses of $(0.07) per share which beat the analyst consensus estimate of $(0.08) by 12.5 percent. This is a 75 percent increase over losses of $(0.28) per share from the same period last year.